Introduction
Cardiac surgery elicits an inflammatory response which is associated with organ dysfunction of varying severity -it may lead from a clinically unrecognized condition to severe multiorgan failure with consecutive death. The inflammatory response is initiated and maintained by activation of several defense systems caused by contact of (heparinized) blood with non-endothelial surfaces during the course of surgery w1-3x. The cardiopulmonary bypass (CPB) circuit is the largest foreign, non-endothelial cell surface and, therefore, often considered to be the most important source of activation of the inflammatory response associated with cardiac surgery. Indeed, it could be demonstrated that the CPB tubes and prime solutions themselves stimulate an inflammatory response w4, 5x.
Several strategies have been explored in order to reduce the inflammatory response to the CPB. In one of these strategies, a filter is used to capture activated leukocytes from the CPB circuit before entering the patient's circulation. Experimental studies had shown that the myocardial *Corresponding author. Klinik fuer Herz-und thorakale Gefaesschirurgie, UK S-H, Campus Luebeck, Ratzeburger Allee 160, 23538 Luebeck, Germany. Tel.: q49-451-500-2108; fax: q49-451-500-2051.
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ischemia-reperfusion injury is blunted by the use of leukocyte-depletion (LD) w6, 7x and also indicated better pulmonary function w8x. Early clinical reports appeared to confirm these findings, but a review as early as 2001 w9x and several reviews in recent years w10-13x concluded that the clinical effects have not been evaluated vigorously and that no recommendations can be made regarding the use of leukocyte-depleting filters in routine cardiac surgery. We reviewed our own experience with LD.
Methods
For 10 weeks, leukocyte-depleting filters were used during all operations with CPB in our department (31 January 2005 until 11 April 2005). The use of leukocyte-depleting filters was stopped after that period for reasons unrelated to their performance, and their clinical efficacy was not explored at that time. We retrospectively decided to analyze the effects of LD. 
Anesthetic management
Premedication, induction and maintenance of anaesthesia were standardized. For premedication, each patient received 1 mg flunitrazepam per os. Anaesthesia was induced with etomidate (0.2-0.3 mgykg), sufentanil (0.5-0.7 mgykg) and pancuronium (0.1 mgykg) and maintained with continuous infusions of propofol (2-6 mgykgyh) and sufentanil (0.5-1.25 mgykgyh). Patients were mechanically ventilated with a tidal volume of 8-10 mlykg predicted body weight in a volume controlled mode. Frequency was adjusted to achieve arterial normocapnia. The positive end-expiratory pressure (PEEP) was set to 5 mbar, inspiration:expiration rate (I:E) ratio of 1:2.
Monitoring included a three-lead electrocardiogram, a transcutaneous oxygen sensor, a radial arterial and a central venous line. All patients with impaired left ventricular function or those scheduled for combined procedures were equipped before surgery with a pulmonary artery catheter for continuous determination of pulmonary artery pressures, automated semicontinuous measurement of cardiac output (CO)ycardiac index (CI) and continuous measurement of mixed venous oxygen saturation (SVO ) (Vigilance ,
Edwards Lifescience, Irvine, USA).
Assembly of CPB and use of leukocyte-depletion filters
The assembly and conduct of the CPB was identical in both groups, except for the use of the LD-filters. The CPB was assembled as follows: a Stöckert S3 machine with roller pumps (Sorin Group); tubes and oxygenator as a set, either Monolite (Sorin Group) or Hilite (Medos; Stolberg, Germany). For arterial cannulation, mainly a Sarns Soft flow cannula (Terumo Europe; Leuven, Belgium) was used, and venous cannulation was usually achieved with 36y51 Fr twostage cannulas (Jostra). Before cannulation, a bolus of 300 IUykg heparin was given. The activated clotting time (ACT) was aimed to be )400 s, monitored periodically and further heparin was given, if necessary. Most operations were performed during moderate (32 8C) systemic hypothermia. Cold antegrade blood cardioplegia according to Buckberg was used and repeated approximately every 20 min. A mean systemic pressure of 60-70 mmHg was aimed for with a CPB flow of 2.0-2.5 lyminym . At the end 2 of CPB, protamine was administered for antagonisation of heparin in a 1:1 fashion.
LD was conducted as follows: an LD-filter (LeukoGuard LGB, Pall, NY, USA) was included into the arterial line instead of a standard 40 mm arterial blood filter (Pall, NY, USA). Leukocyte filtration started with the beginning of extracorporeal circulation and was conducted until its end. A second LD-filter (LeukoGuard BC, Pall, NY, USA) was included into the cardioplegia delivery line. Blood products (including residual blood from the CPB circuit after decannulation) were transfused using standard transfusion lines.
Postoperative care
After surgery, all patients were transferred to the intensive care unit (ICU). The universal use of LD filters had not been announced to the ICU staff. All patients were mechanically ventilated with biphasic airway pressure or pressure support ventilation as long as clinically appropriate. Pressures were adjusted to deliver a tidal volume of 8-10 mly kg body weight and PEEP was set to 7 mbar. Patients were sedated with continuous infusion of propofol and intermittent boli of piritramid or pethidin. Extubation was performed when haemodynamics were stable for half an hour, temperature was more than 36 8C, and the patients breathed spontaneously (pressure support F10-12 mbar and )PEEP, tidal volume G5 mlykg, respiratory rate F25 min ) reach- -45 mmHg) and were cooperative. Fluid management was adjusted to achieve and maintain a central venous pressure between 8 and 12 mmHg. Volume replacement was performed with Ringer's solution and gelatine polysuccinate, as appropriate. Haematocrit was maintained above 0.27 by transfusion of packed red blood cells. Dobutamine was administered on a first line basis, if CI was -2.5 lyminym .
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Noradrenaline was administered, if mean arterial pressure was -65 mmHg despite CI )2.5 lyminym . Vasodilators 2 (urapidil, sodium nitroprusside) were given, if the mean arterial pressure was )90 mmHg.
Data collection
Using the records of the cardiotechnicians, the period during which leukocyte-depleting filters were used was identified. During that period, 266 patients were operated and form the LD-group. The same number of patients was included in the control-group (C) by taking 133 patients each from the weeks immediately before and after that period. Having defined these groups, the demographics of the patients and their co-morbidities as well as data on 30-day mortality and morbidity were extracted from our quality control database. Entries into that database were made during the hospital stay and the mandatory 30-day surveillance period. Standarized definitions as provided by the Bundesgeschaeftsstelle Qualitaetssicherung (BQS) (Duesseldorf, Germany) were used.
Values of total leukocyte count, creatine kinase (CK), and creatine kinase myocardial band (CKMB) for both groups were drawn from the database of the Institute for Clinical Chemistry. Due to the retrospective nature of the study, the number of blood examinations vary from patient to patient. Usually, in addition to a preoperative measurement, total leukocyte count was determined at the time of arrival on the ICU, on the next morning, and once daily thereafter; CK and CKMB were measured at the time of arrival on the ICU, 6 h thereafter, on the next morning, and once daily thereafter. To account for the differences in the arrival time on ICU, postoperative days (PODs) are counted in 24-h intervals that started at the end of CPB, and not in calendrical days. The number of laboratory measurements in each group on each of the first PODs is given in Table 1 and was comparable between the groups.
Statistics
Data are presented as absolute numbers and percentages, mean"standard deviation, or median with minimum and maximum as appropriate. Relative frequencies were compared using the x -or Fisher's exact-test. The laboratory 2 Operative day, all measurements from end of cardiopulmonary bypass (CPB) up to 24 h thereafter; POD, postoperative day as calculated in 24 h-intervals after the end of the operative day; CK(MB), creatine kinase(myocardial band). LV, left ventricle or ventricular; LVEDP, LV end-diastolic pressure; COPD, chronic obstructive pulmonary disease; CABG, coronary artery bypass grafting; rec.y repl., reconstruction or replacement; repl., replacement; res., resection; ECC, (duration of) extracorporeal circulation; XClamp, (duration of) aortic crossclamping; n*, denotes the number of patients with transfusions; n , denotes the median (and minimum to maximum) number of units transfused to those patients † who received transfusions; percentages may add to more than 100 because of rounding. data were analyzed using the following intervals: preoperative; end-of-CPB to 24 h later (labelled as operative day); and intervals of 24 h thereafter (labelled as PODs). Because the number of measurements per patient varied, a repeated measurement design was not followed. Instead, as an overall measure the sum of all measurements (preoperative to third POD) was compared between the groups using the unpaired Mann-Whitney U-test. In addition, each variable was compared between the groups within each interval using the unpaired Mann-Whitney U-test; multiple comparisons were corrected using Bonferoni's method. A P-0.05 was considered to indicate statistical significance. All analyses were performed using SPSS for Windows, release 9. Table 2 shows the main demographic characteristics and comorbidities of the patients. No significant differences between the groups were observed. The patients underwent a wide spectrum of surgery with comparable distribution including the frequency of reoperations and emergency surgery (Table 2) .
Results
Preoperatively, the leukocyte count tended to be lower in the LD-group (7961"2415 vs. 8444"2951, Ps0.050). Despite this, however, the leukocyte count was not different between the groups at any later time (Fig. 1) . In an effort to analyse the effect of the duration of filtration on leukocyte count, quartiles of the groups defined by the duration of CPB (which was equal to that of filtration) were also compared: no differences were found, neither in the quartile with the lowest duration of CPB (Ps0.71 on the day Fig. 1 . Leukocyte count over time. The boxes represent the 25th-75th percentile; the line within the box marks the median. The whiskers indicate the 10th and 90th percentile. There was a trend towards lower preoperative leukocyte counts in the leukodepletion-group (white boxes) as compared to the control-group (gray boxes; Ps0.050). There were no group differences at any of the later time points woverall comparison: Ps0.19; comparison per day: day of surgery to postoperative day (POD) 3: Ps0. 22, Ps0.41, Ps0.46, and Ps0.19x . Fig. 2 . CKMB release over time. The boxes represent the 25th-75th percentile; the line within the box marks the median. The whiskers indicate the 10th and 90th percentile. White boxes indicate the CKMB values of the leukodepletion-group, gray boxes those of the control-group. There were no differences between the groups, neither preoperatively (Ps0.43), nor at any later point woverall comparison: Ps0.31; comparison per day: day of surgery to postoperative day (POD) 3: Ps0.14, Ps0.64, Ps0.66, and Ps0.90x . CKMB, creatine kinase myocardial band. of surgery and P)0.20 on every other day), nor in the quartile with the longest duration of CPB (Ps0.38 on the day of surgery and P)0.40 on every other day).
No effect on CK or CKMB (Fig. 2) release was found. The 30-day mortality was rather low (total: ns4% or 0.8%, respectively) and did not differ significantly between the groups (Table 3) . Likewise, no differences regarding major postoperative morbidity was observed ( Table 3) . The proportion of patients extubated within 12 h postoperatively was significantly higher in the LD-group (69% vs. 60% in the C, Ps0.029). However, neither the prevalence of pneumonia (9% vs. 7%, Ps0.41) or for the need of reintubation (5% vs. 4%, Ps0.53) was significantly different between the groups (Table 3) . If respiratory insufficiency (defined as presence of pneumonia andyor need for non-invasive ventilation, pleural puncture, or reintubation) is looked at, there appeared to be a tendency towards a reduced prevalence in the LD-group (21% vs. 15%, Ps0.063; Table 3 ).
Discussion
Our study is one of the largest to date on intraoperative LD, and it was performed on patients who had -on average -a low to moderate surgical risk. In this setting, we did not observe a clear benefit of routine intraoperative LD.
Leukocyte filters were introduced into cardiac surgery in an effort to alleviate the perioperative inflammatory response. This strategy was the corollary of the longrecognized observation that some patients suffer from odd problems probably due to an excessive inflammatory reaction after cardiac surgery ('pump lung') w14x and the discovery that cardiac surgery with CPB elicits an inflammatory response in virtually all patients w1, 2x. As a result, several pharmacological agents and surface modifications of the CPB circuit have been used to alleviate the inflammatory response. These interventions have often been successful in reducing markers of inflammation, but provided inconsistent clinical results and the potential for serious side effects. Most of these interventions were aimed at early stages of the cascade of inflammation -leaving open the possibility of alternative ways of activation of the inflammatory response. As activation of all defense systems triggering the inflammatory cascade finally results in activation of several types of cells, a more practical way of reducing the inflammatory response might be to directly target or remove these effector cells.
After early enthusiasm for LD in cardiac surgery, interest slowly vanished as the results were very inconsistent. Although, it is still widely believed that LD is beneficial in high-risk patients w12x, this remains unproven w10, 15x. There are several explanations why the existing studies were inconclusive: small number of patients in most studies; hardly any randomized trials; different patient populations; focus on laboratory effectiveness instead of clinical endpoints.
Another very important difference between the studies pertains to the conduct of LD during CPB. The strategies applied vary (amongst others) regarding the timing and duration of filtration (during cross-clamp andyor during reperfusion; intermittent vs. continuous), regarding the position of the filter (in the arterial andyor cardioplegic line), and -to a lesser degree -regarding the filters used. In addition, processing of residual blood from the CPB circuit also varied.
In most settings -including our own -the long-known facts that filter capacity varies (amongst others with flow, volume, and number of leukocytes to be filtered) and that filters become exhausted w16-18x has been largely ignored. As a result, leukocyte count will not necessarily be reduced by the use of filters, leukocyte function may be normal w19x, or leukocyte activation may even be increased w20, 21x. Therefore, the strategy chosen by our group might have biased the results towards the null-hypothesis of no *Presence of pneumonia andyor need for non-invasive ventilation, pleural puncture or drainage, or reintubation; n*, denotes the number of patients with transfusions; n , denotes the median (and minimum to maximum) number of units transfused to those patients who received transfusions. † difference between the groups. However, the different strategies of filtration have not been vigoursly tested against each other, and the results are -again -inconclusive w10x. A recent experimental study suggests that shortterm rather than prolonged LD is more efficacious w22x. In our own study, we did not find evidence that a shorter duration of filtration was associated with higher LD efficacy (comparison of the quartiles of patients with the shortest and longest duration of CPB). A comparison regarding clinical endpoints for these patients was not performed as too many other factors influence the outcome of patients with long vs. short CPB duration.
Several clinical studies have suggested that LD during cardiac surgery is especially advantageous for postoperative lung function w23-25x. From our own data, we can neither support nor refute such claims. The only variable with a significant difference between the groups was the fraction of patients extubated within 12 h after surgery. Time to extubation, however, is dependent on many factors and should not be regarded as proof of better postoperative lung function. The prevalence of pneumonia or the need for reintubation -which are more relevant clinical variables -were not significantly different between the groups, but there appeared to be a trend towards a lower prevalence of overall pulmonary problems (defined as presence of pneumonia andyor need for non-invasive ventilation, pleural puncture, or reintubation). Due to the retrospective nature of the study, we cannot provide more sophisticated pre-or postoperative measures of lung function.
Limitations of the study
This is a retrospective clinical study with all its methodological limitations. Although our study design appears to have resulted in well-matched groups regarding almost all variables, unrecognized differences between the groups or in the treatment of the patients might have existed and influenced our results. It is noteworthy that the preoperative leukocyte count tended to be lower in the leukodepletion-group; despite this, we found no evidence that the leukocytes in the leukodepletion-group were lower during the postoperative period questioning the efficacy of the leukodepletion-strategy used. However, no variables especially aimed at the examination of the efficacy of LD were studied. However, besides its size, the fact that routine practice and a broad variety of types of surgery were examined can be regarded as a strength of our study.
Conclusions
In a retrospective study on 522 adult patients, no clear benefit of routine intraoperative LD was evident. Evidence from the literature suggests that continuous leukofiltration might not be the optimal strategy. Therefore, the strategy chosen by our group might have biased the results towards clinical ineffectivity of LD.
